nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—TEK—artery—thoracic aortic aneurysm	0.0166	0.129	CbGeAlD
Ponatinib—SRC—artery—thoracic aortic aneurysm	0.0147	0.115	CbGeAlD
Ponatinib—KDR—artery—thoracic aortic aneurysm	0.0135	0.106	CbGeAlD
Ponatinib—BCR—cardiac atrium—thoracic aortic aneurysm	0.0072	0.0562	CbGeAlD
Ponatinib—FGFR3—spinal cord—thoracic aortic aneurysm	0.00699	0.0546	CbGeAlD
Ponatinib—FGFR1—cardiac atrium—thoracic aortic aneurysm	0.0064	0.05	CbGeAlD
Ponatinib—BCR—spinal cord—thoracic aortic aneurysm	0.00605	0.0472	CbGeAlD
Ponatinib—FGFR1—spinal cord—thoracic aortic aneurysm	0.00538	0.042	CbGeAlD
Ponatinib—TEK—cardiac atrium—thoracic aortic aneurysm	0.00522	0.0408	CbGeAlD
Ponatinib—RET—spinal cord—thoracic aortic aneurysm	0.00482	0.0376	CbGeAlD
Ponatinib—SRC—cardiac atrium—thoracic aortic aneurysm	0.00464	0.0362	CbGeAlD
Ponatinib—FGFR2—spinal cord—thoracic aortic aneurysm	0.00458	0.0357	CbGeAlD
Ponatinib—TEK—spinal cord—thoracic aortic aneurysm	0.00439	0.0343	CbGeAlD
Ponatinib—KDR—cardiac atrium—thoracic aortic aneurysm	0.00427	0.0333	CbGeAlD
Ponatinib—PDGFRA—spinal cord—thoracic aortic aneurysm	0.00398	0.031	CbGeAlD
Ponatinib—SRC—spinal cord—thoracic aortic aneurysm	0.0039	0.0304	CbGeAlD
Ponatinib—KDR—spinal cord—thoracic aortic aneurysm	0.00359	0.028	CbGeAlD
Ponatinib—ABL1—cardiac atrium—thoracic aortic aneurysm	0.00329	0.0257	CbGeAlD
Ponatinib—KIT—spinal cord—thoracic aortic aneurysm	0.00318	0.0248	CbGeAlD
Ponatinib—ABL1—spinal cord—thoracic aortic aneurysm	0.00277	0.0216	CbGeAlD
Ponatinib—KDR—EPH-Ephrin signaling—MMP9—thoracic aortic aneurysm	0.00186	0.00213	CbGpPWpGaD
Ponatinib—KIT—Signaling by NGF—ADAM17—thoracic aortic aneurysm	0.00184	0.00211	CbGpPWpGaD
Ponatinib—LCK—Signaling by EGFR—ADAM17—thoracic aortic aneurysm	0.00183	0.0021	CbGpPWpGaD
Ponatinib—LCK—Signaling by EGFR in Cancer—ADAM17—thoracic aortic aneurysm	0.00181	0.00208	CbGpPWpGaD
Ponatinib—LYN—Platelet activation, signaling and aggregation—TGFB2—thoracic aortic aneurysm	0.00181	0.00207	CbGpPWpGaD
Ponatinib—ABL1—Integrated Breast Cancer Pathway—TGFBR2—thoracic aortic aneurysm	0.00181	0.00207	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.0018	0.00206	CbGpPWpGaD
Ponatinib—SRC—Androgen receptor signaling pathway—SMAD3—thoracic aortic aneurysm	0.00178	0.00204	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—MYH11—thoracic aortic aneurysm	0.00176	0.00201	CbGpPWpGaD
Ponatinib—ABCG2—spinal cord—thoracic aortic aneurysm	0.00174	0.0136	CbGeAlD
Ponatinib—FGFR1—Signaling by NGF—ADAM17—thoracic aortic aneurysm	0.00174	0.002	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by NGF—ADAM17—thoracic aortic aneurysm	0.00174	0.002	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—MYH11—thoracic aortic aneurysm	0.00173	0.00198	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—MYH11—thoracic aortic aneurysm	0.00172	0.00197	CbGpPWpGaD
Ponatinib—SRC—Plasma membrane estrogen receptor signaling—MMP9—thoracic aortic aneurysm	0.0017	0.00195	CbGpPWpGaD
Ponatinib—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—thoracic aortic aneurysm	0.00167	0.00191	CbGpPWpGaD
Ponatinib—KDR—Axon guidance—ADAM10—thoracic aortic aneurysm	0.00164	0.00189	CbGpPWpGaD
Ponatinib—LYN—LPA receptor mediated events—MMP9—thoracic aortic aneurysm	0.00164	0.00188	CbGpPWpGaD
Ponatinib—SRC—Signaling by EGFR—ADAM17—thoracic aortic aneurysm	0.00162	0.00186	CbGpPWpGaD
Ponatinib—SRC—Signaling by EGFR in Cancer—ADAM17—thoracic aortic aneurysm	0.00161	0.00184	CbGpPWpGaD
Ponatinib—LYN—EPH-Ephrin signaling—MMP2—thoracic aortic aneurysm	0.0016	0.00184	CbGpPWpGaD
Ponatinib—BCR—Disease—ADAM17—thoracic aortic aneurysm	0.0016	0.00184	CbGpPWpGaD
Ponatinib—BCR—Disease—TGFBR1—thoracic aortic aneurysm	0.0016	0.00184	CbGpPWpGaD
Ponatinib—SRC—LPA receptor mediated events—MMP2—thoracic aortic aneurysm	0.00158	0.00181	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—ADAM17—thoracic aortic aneurysm	0.00156	0.00179	CbGpPWpGaD
Ponatinib—SRC—Senescence and Autophagy in Cancer—SMAD3—thoracic aortic aneurysm	0.00156	0.00179	CbGpPWpGaD
Ponatinib—FGFR3—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.00154	0.00177	CbGpPWpGaD
Ponatinib—SRC—AGE/RAGE pathway—MMP2—thoracic aortic aneurysm	0.00154	0.00177	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—TGFBR1—thoracic aortic aneurysm	0.00154	0.00176	CbGpPWpGaD
Ponatinib—SRC—EPH-ephrin mediated repulsion of cells—MMP9—thoracic aortic aneurysm	0.0015	0.00172	CbGpPWpGaD
Ponatinib—LCK—Platelet activation, signaling and aggregation—TGFB2—thoracic aortic aneurysm	0.00148	0.0017	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—PRKG1—thoracic aortic aneurysm	0.00148	0.00169	CbGpPWpGaD
Ponatinib—SRC—TGF-beta Signaling Pathway—TGFBR2—thoracic aortic aneurysm	0.00147	0.00168	CbGpPWpGaD
Ponatinib—LCK—Signaling by EGFR—ADAM10—thoracic aortic aneurysm	0.0014	0.00161	CbGpPWpGaD
Ponatinib—LCK—Signaling by EGFR in Cancer—ADAM10—thoracic aortic aneurysm	0.00139	0.00159	CbGpPWpGaD
Ponatinib—SRC—FGF signaling pathway—MMP9—thoracic aortic aneurysm	0.00136	0.00156	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.00135	0.00155	CbGpPWpGaD
Ponatinib—ABCB1—HIF-1-alpha transcription factor network—SMAD3—thoracic aortic aneurysm	0.00134	0.00153	CbGpPWpGaD
Ponatinib—LYN—CXCR4-mediated signaling events—MMP9—thoracic aortic aneurysm	0.00132	0.00151	CbGpPWpGaD
Ponatinib—SRC—Platelet activation, signaling and aggregation—TGFB2—thoracic aortic aneurysm	0.00131	0.00151	CbGpPWpGaD
Ponatinib—SRC—TGF-beta Signaling Pathway—SMAD3—thoracic aortic aneurysm	0.0013	0.00149	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—ADAM17—thoracic aortic aneurysm	0.00128	0.00147	CbGpPWpGaD
Ponatinib—LCK—Signaling by NGF—ADAM17—thoracic aortic aneurysm	0.00126	0.00144	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—MYH11—thoracic aortic aneurysm	0.00125	0.00144	CbGpPWpGaD
Ponatinib—SRC—Signaling by EGFR—ADAM10—thoracic aortic aneurysm	0.00124	0.00142	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.00124	0.00142	CbGpPWpGaD
Ponatinib—SRC—Signaling by EGFR in Cancer—ADAM10—thoracic aortic aneurysm	0.00123	0.00141	CbGpPWpGaD
Ponatinib—BCR—Disease—ADAM10—thoracic aortic aneurysm	0.00123	0.00141	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—ADAM17—thoracic aortic aneurysm	0.00122	0.0014	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.00122	0.00139	CbGpPWpGaD
Ponatinib—FGFR1—Axon guidance—ADAM10—thoracic aortic aneurysm	0.00121	0.00139	CbGpPWpGaD
Ponatinib—LYN—EPH-Ephrin signaling—MMP9—thoracic aortic aneurysm	0.0012	0.00138	CbGpPWpGaD
Ponatinib—SRC—LPA receptor mediated events—MMP9—thoracic aortic aneurysm	0.00119	0.00136	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—PRKG1—thoracic aortic aneurysm	0.00117	0.00135	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.00117	0.00135	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—PRKG1—thoracic aortic aneurysm	0.00117	0.00134	CbGpPWpGaD
Ponatinib—SRC—EPH-Ephrin signaling—MMP2—thoracic aortic aneurysm	0.00116	0.00133	CbGpPWpGaD
Ponatinib—SRC—AGE/RAGE pathway—MMP9—thoracic aortic aneurysm	0.00116	0.00133	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.00115	0.00132	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.00115	0.00132	CbGpPWpGaD
Ponatinib—BCR—Disease—TGFBR2—thoracic aortic aneurysm	0.00114	0.0013	CbGpPWpGaD
Ponatinib—FGFR4—Disease—ADAM17—thoracic aortic aneurysm	0.00113	0.00129	CbGpPWpGaD
Ponatinib—FGFR4—Disease—TGFBR1—thoracic aortic aneurysm	0.00113	0.00129	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.00112	0.00129	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.00112	0.00129	CbGpPWpGaD
Ponatinib—SRC—Signaling by NGF—ADAM17—thoracic aortic aneurysm	0.00111	0.00128	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—PRKG1—thoracic aortic aneurysm	0.00109	0.00125	CbGpPWpGaD
Ponatinib—KDR—Extracellular matrix organization—MMP2—thoracic aortic aneurysm	0.00108	0.00124	CbGpPWpGaD
Ponatinib—LCK—CXCR4-mediated signaling events—MMP9—thoracic aortic aneurysm	0.00108	0.00124	CbGpPWpGaD
Ponatinib—LYN—Axon guidance—ADAM10—thoracic aortic aneurysm	0.00106	0.00122	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.00106	0.00122	CbGpPWpGaD
Ponatinib—ABL1—Axon guidance—ADAM10—thoracic aortic aneurysm	0.00106	0.00122	CbGpPWpGaD
Ponatinib—KIT—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.00104	0.0012	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.00101	0.00116	CbGpPWpGaD
Ponatinib—BCR—Disease—SMAD3—thoracic aortic aneurysm	0.001	0.00115	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.00099	0.00114	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.000988	0.00113	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—PRKG1—thoracic aortic aneurysm	0.000962	0.0011	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000961	0.0011	CbGpPWpGaD
Ponatinib—SRC—CXCR4-mediated signaling events—MMP9—thoracic aortic aneurysm	0.000957	0.0011	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000954	0.00109	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—TGFB2—thoracic aortic aneurysm	0.000932	0.00107	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—TGFB2—thoracic aortic aneurysm	0.000928	0.00106	CbGpPWpGaD
Ponatinib—KDR—Axon guidance—MMP2—thoracic aortic aneurysm	0.00092	0.00106	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—thoracic aortic aneurysm	0.00091	0.00104	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—ADAM17—thoracic aortic aneurysm	0.000904	0.00104	CbGpPWpGaD
Ponatinib—SRC—EPH-Ephrin signaling—MMP9—thoracic aortic aneurysm	0.000874	0.001	CbGpPWpGaD
Ponatinib—LYN—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.000871	0.000999	CbGpPWpGaD
Ponatinib—FGFR4—Disease—ADAM10—thoracic aortic aneurysm	0.000865	0.000992	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.000864	0.000991	CbGpPWpGaD
Ponatinib—ABCB1—spinal cord—thoracic aortic aneurysm	0.00086	0.00672	CbGeAlD
Ponatinib—BCR—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.00086	0.000986	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—PRKG1—thoracic aortic aneurysm	0.000852	0.000977	CbGpPWpGaD
Ponatinib—FGFR3—Disease—ADAM17—thoracic aortic aneurysm	0.000835	0.000958	CbGpPWpGaD
Ponatinib—FGFR3—Disease—TGFBR1—thoracic aortic aneurysm	0.000835	0.000958	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.000832	0.000954	CbGpPWpGaD
Ponatinib—KDR—Extracellular matrix organization—MMP9—thoracic aortic aneurysm	0.000815	0.000934	CbGpPWpGaD
Ponatinib—FGFR4—Disease—TGFBR2—thoracic aortic aneurysm	0.0008	0.000918	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000796	0.000912	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.00079	0.000906	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.00079	0.000906	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—ADAM10—thoracic aortic aneurysm	0.000773	0.000886	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—TGFB2—thoracic aortic aneurysm	0.000764	0.000877	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.00076	0.000872	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.000756	0.000867	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—PRKG1—thoracic aortic aneurysm	0.000751	0.000861	CbGpPWpGaD
Ponatinib—KIT—Immune System—PRKG1—thoracic aortic aneurysm	0.000737	0.000845	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.000736	0.000844	CbGpPWpGaD
Ponatinib—LCK—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.000714	0.000819	CbGpPWpGaD
Ponatinib—FGFR4—Disease—SMAD3—thoracic aortic aneurysm	0.000708	0.000812	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000707	0.000811	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000706	0.000809	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000704	0.000807	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—PRKG1—thoracic aortic aneurysm	0.0007	0.000802	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—PRKG1—thoracic aortic aneurysm	0.000698	0.0008	CbGpPWpGaD
Ponatinib—KDR—Axon guidance—MMP9—thoracic aortic aneurysm	0.000692	0.000793	CbGpPWpGaD
Ponatinib—FGFR1—Axon guidance—MMP2—thoracic aortic aneurysm	0.000677	0.000777	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—TGFB2—thoracic aortic aneurysm	0.000677	0.000776	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000657	0.000753	CbGpPWpGaD
Ponatinib—FGFR3—Disease—ADAM10—thoracic aortic aneurysm	0.00064	0.000734	CbGpPWpGaD
Ponatinib—SRC—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.000632	0.000725	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000622	0.000713	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—ADAM17—thoracic aortic aneurysm	0.000622	0.000713	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000619	0.00071	CbGpPWpGaD
Ponatinib—LYN—Immune System—PRKG1—thoracic aortic aneurysm	0.000615	0.000706	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000615	0.000705	CbGpPWpGaD
Ponatinib—ABL1—Immune System—PRKG1—thoracic aortic aneurysm	0.000613	0.000703	CbGpPWpGaD
Ponatinib—KIT—Immune System—ADAM17—thoracic aortic aneurysm	0.000611	0.000701	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000606	0.000695	CbGpPWpGaD
Ponatinib—LYN—Axon guidance—MMP2—thoracic aortic aneurysm	0.000596	0.000683	CbGpPWpGaD
Ponatinib—ABL1—Axon guidance—MMP2—thoracic aortic aneurysm	0.000593	0.00068	CbGpPWpGaD
Ponatinib—FGFR3—Disease—TGFBR2—thoracic aortic aneurysm	0.000592	0.000679	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000585	0.000671	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000585	0.000671	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—ADAM17—thoracic aortic aneurysm	0.00058	0.000665	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—ADAM17—thoracic aortic aneurysm	0.000578	0.000663	CbGpPWpGaD
Ponatinib—FGFR2—Disease—TGFBR1—thoracic aortic aneurysm	0.000574	0.000659	CbGpPWpGaD
Ponatinib—FGFR2—Disease—ADAM17—thoracic aortic aneurysm	0.000574	0.000659	CbGpPWpGaD
Ponatinib—KIT—Disease—ADAM17—thoracic aortic aneurysm	0.000564	0.000647	CbGpPWpGaD
Ponatinib—KIT—Disease—TGFBR1—thoracic aortic aneurysm	0.000564	0.000647	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.00056	0.000643	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.000551	0.000632	CbGpPWpGaD
Ponatinib—FGFR1—Disease—TGFBR1—thoracic aortic aneurysm	0.000535	0.000614	CbGpPWpGaD
Ponatinib—FGFR1—Disease—ADAM17—thoracic aortic aneurysm	0.000535	0.000614	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—TGFBR1—thoracic aortic aneurysm	0.000534	0.000612	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—ADAM17—thoracic aortic aneurysm	0.000534	0.000612	CbGpPWpGaD
Ponatinib—FGFR3—Disease—SMAD3—thoracic aortic aneurysm	0.000524	0.000601	CbGpPWpGaD
Ponatinib—LYN—Immune System—ADAM17—thoracic aortic aneurysm	0.00051	0.000585	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000509	0.000584	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000509	0.000584	CbGpPWpGaD
Ponatinib—FGFR1—Axon guidance—MMP9—thoracic aortic aneurysm	0.000509	0.000584	CbGpPWpGaD
Ponatinib—ABL1—Immune System—ADAM17—thoracic aortic aneurysm	0.000508	0.000582	CbGpPWpGaD
Ponatinib—LCK—Immune System—PRKG1—thoracic aortic aneurysm	0.000504	0.000579	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000496	0.000569	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000494	0.000566	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000485	0.000557	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000483	0.000554	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000477	0.000547	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000452	0.000519	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000451	0.000518	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000451	0.000517	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000448	0.000514	CbGpPWpGaD
Ponatinib—LYN—Axon guidance—MMP9—thoracic aortic aneurysm	0.000448	0.000514	CbGpPWpGaD
Ponatinib—SRC—Immune System—PRKG1—thoracic aortic aneurysm	0.000447	0.000512	CbGpPWpGaD
Ponatinib—ABL1—Axon guidance—MMP9—thoracic aortic aneurysm	0.000446	0.000511	CbGpPWpGaD
Ponatinib—FGFR2—Disease—ADAM10—thoracic aortic aneurysm	0.00044	0.000505	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—MMP2—thoracic aortic aneurysm	0.000432	0.000496	CbGpPWpGaD
Ponatinib—KIT—Disease—ADAM10—thoracic aortic aneurysm	0.000432	0.000496	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000425	0.000488	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000423	0.000485	CbGpPWpGaD
Ponatinib—LCK—Immune System—ADAM17—thoracic aortic aneurysm	0.000418	0.000479	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000415	0.000476	CbGpPWpGaD
Ponatinib—FGFR1—Disease—ADAM10—thoracic aortic aneurysm	0.00041	0.00047	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—ADAM10—thoracic aortic aneurysm	0.000409	0.000469	CbGpPWpGaD
Ponatinib—FGFR2—Disease—TGFBR2—thoracic aortic aneurysm	0.000407	0.000467	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000402	0.000461	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000402	0.000461	CbGpPWpGaD
Ponatinib—KIT—Disease—TGFBR2—thoracic aortic aneurysm	0.0004	0.000459	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000398	0.000456	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000395	0.000453	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000395	0.000453	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.00039	0.000448	CbGpPWpGaD
Ponatinib—LCK—Disease—ADAM17—thoracic aortic aneurysm	0.000386	0.000443	CbGpPWpGaD
Ponatinib—LCK—Disease—TGFBR1—thoracic aortic aneurysm	0.000386	0.000443	CbGpPWpGaD
Ponatinib—FGFR1—Disease—TGFBR2—thoracic aortic aneurysm	0.00038	0.000435	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—TGFBR2—thoracic aortic aneurysm	0.000379	0.000434	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000375	0.00043	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000375	0.00043	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000374	0.000429	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000374	0.000429	CbGpPWpGaD
Ponatinib—SRC—Immune System—ADAM17—thoracic aortic aneurysm	0.00037	0.000424	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000367	0.000421	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000363	0.000417	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—MMP9—thoracic aortic aneurysm	0.000362	0.000415	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000361	0.000414	CbGpPWpGaD
Ponatinib—FGFR2—Disease—SMAD3—thoracic aortic aneurysm	0.00036	0.000413	CbGpPWpGaD
Ponatinib—KIT—Disease—SMAD3—thoracic aortic aneurysm	0.000354	0.000406	CbGpPWpGaD
Ponatinib—SRC—Disease—ADAM17—thoracic aortic aneurysm	0.000342	0.000392	CbGpPWpGaD
Ponatinib—SRC—Disease—TGFBR1—thoracic aortic aneurysm	0.000342	0.000392	CbGpPWpGaD
Ponatinib—FGFR1—Disease—SMAD3—thoracic aortic aneurysm	0.000336	0.000385	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—SMAD3—thoracic aortic aneurysm	0.000335	0.000384	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.00033	0.000378	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.00033	0.000378	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000326	0.000374	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—MMP9—thoracic aortic aneurysm	0.000325	0.000373	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—MMP9—thoracic aortic aneurysm	0.00032	0.000366	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000319	0.000366	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000318	0.000365	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000308	0.000354	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000308	0.000353	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000303	0.000347	CbGpPWpGaD
Ponatinib—LCK—Disease—ADAM10—thoracic aortic aneurysm	0.000296	0.000339	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000289	0.000331	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000287	0.000329	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000287	0.000329	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000285	0.000327	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.00028	0.000321	CbGpPWpGaD
Ponatinib—LCK—Disease—TGFBR2—thoracic aortic aneurysm	0.000274	0.000314	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.00027	0.00031	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.00027	0.00031	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000266	0.000305	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000265	0.000304	CbGpPWpGaD
Ponatinib—SRC—Disease—ADAM10—thoracic aortic aneurysm	0.000262	0.0003	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—MMP9—thoracic aortic aneurysm	0.000255	0.000292	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000253	0.00029	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000252	0.000289	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000248	0.000284	CbGpPWpGaD
Ponatinib—SRC—Disease—TGFBR2—thoracic aortic aneurysm	0.000242	0.000278	CbGpPWpGaD
Ponatinib—LCK—Disease—SMAD3—thoracic aortic aneurysm	0.000242	0.000278	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000239	0.000274	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000239	0.000274	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000235	0.00027	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000234	0.000269	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000234	0.000268	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000232	0.000266	CbGpPWpGaD
Ponatinib—SRC—Disease—SMAD3—thoracic aortic aneurysm	0.000214	0.000246	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000207	0.000238	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000207	0.000237	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000192	0.00022	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—MMP9—thoracic aortic aneurysm	0.000188	0.000216	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000183	0.00021	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.00017	0.000195	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.00017	0.000194	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—MMP9—thoracic aortic aneurysm	0.000164	0.000188	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.00015	0.000172	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MMP9—thoracic aortic aneurysm	0.00013	0.000149	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MMP9—thoracic aortic aneurysm	0.000127	0.000146	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MMP9—thoracic aortic aneurysm	0.000121	0.000139	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MMP9—thoracic aortic aneurysm	0.00012	0.000138	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MMP9—thoracic aortic aneurysm	0.000106	0.000122	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MMP9—thoracic aortic aneurysm	8.71e-05	9.99e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MMP9—thoracic aortic aneurysm	7.71e-05	8.84e-05	CbGpPWpGaD
